EP3077521B1 - Novel genome alteration system for microorganisms - Google Patents

Novel genome alteration system for microorganisms Download PDF

Info

Publication number
EP3077521B1
EP3077521B1 EP14815085.7A EP14815085A EP3077521B1 EP 3077521 B1 EP3077521 B1 EP 3077521B1 EP 14815085 A EP14815085 A EP 14815085A EP 3077521 B1 EP3077521 B1 EP 3077521B1
Authority
EP
European Patent Office
Prior art keywords
microorganism
endonuclease
homology
construct
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP14815085.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3077521A1 (en
Inventor
Jean-Marc Georges Daran
Jan-Maarten Anton GEERTMAN
Irina BOLAT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heineken Supply Chain BV
Original Assignee
Heineken Supply Chain BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heineken Supply Chain BV filed Critical Heineken Supply Chain BV
Priority to PL14815085T priority Critical patent/PL3077521T3/pl
Publication of EP3077521A1 publication Critical patent/EP3077521A1/en
Application granted granted Critical
Publication of EP3077521B1 publication Critical patent/EP3077521B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces

Definitions

  • the invention relates to the fields of molecular biology and genetic engineering of microorganisms, especially of yeast.
  • Homologous recombination in microorganisms is based on a double strand break repair mechanism, which joins the DNA fragments.
  • a double stranded DNA break is detected, an exonuclease degrades both 5' ends, after which strand invasion of homologous template takes place.
  • the DNA synthesis mechanism repairs both strands and DNA ligation completes the process without any deletions [ Storici et al., (2003). PNAS USA 100: 14994-9 ; Haber, (2000). Trends Genet 16: 259-264 ].
  • homologous recombination repair will occur with as little as 30 bp of homology, it is much more efficient with 200-400 bp [ Sugawara et al., (2000). Mol Cell Biol 20: 5300-5309 ].
  • An alternative method to repair a double stranded break is based on non-homologous end joining, where the heterodimer of so called Ku proteins grasps the broken chromosome ends, which promotes the binding of additional proteins. These additional proteins process the DNA ends and ligate them, which generally creates a deletion of several nucleotides [ Storici et al., (2003). PNAS USA 100: 14994-9 ].
  • the homologous recombination repair pathway was successfully used to construct a plasmid from two co-transformed DNA fragments, which contained homologous regions [ Ma et al., (1987). Gene, 58: 201-16.26 ].
  • Microorganisms, and especially S. cerevisiae species, are tractable organisms for developing new techniques [ Kumar and Snyder, (2001). Nat Rev Genet 2: 302-312 ], in which genetic alteration is either done with double stranded DNA or with single stranded DNA [ Orr-Weaver et al., (1981). PNAS USA 78: 6354-6358 ; Moerschell et al., (1988). PNAS USA 85: 524-528 ].
  • cerevisiae can take up and assemble at least 38 overlapping single stranded oligonucleotides and a linear double-stranded vector in one transformation event with overlaps between oligonucleotides as few as 20 base pairs and with a length of 200 nucleotides [ Gibson, (2009). Nucleic Acids Res 37: 6984-6990 ].
  • Targeting efficiency in part depends on the presence of a long homologous sequence in a targeting construct [ Davidson and Schiestl, (2000). Curr Genet 38: 188-190 ].
  • homologous recombination in some microorganisms such as for example most strains of the lager brewing yeast Saccharomyces pastorianus, is difficult to achieve, even in the presence of long homologous sequences in the targeting construct ( Murakami et al., 2012. Yeast, 29: 155-165 .
  • False positives usually are the results of random single cross over events.
  • the present invention overcomes the problem of efficient targeting by providing a set of targeting constructs, in which the correct expression of a selection marker depends on a recombination event between the targeting constructs. It was found that the occurrence of a recombination event between the targeting constructs is markedly enhanced after integration of the targeting constructs in the correct targeting locus. Therefore, the target system of the present invention, comprising a set of targeting constructs, greatly enhances the percentage of correctly integrated constructs in microorganisms that express the selection marker, compared to a one-vector targeting system. Splitting the marker in two limits the occurrence of false positives due to single cross over events. The split marker approach improves the ratio of true positives over false positives ( Nielsen et al., 2006. Fungal Gen Biol 43: 54-64 ).
  • the invention provides a set of targeting constructs, comprising a first construct comprising a first region of homology with a target genome of a microorganism, a recognition site for an endonuclease, and a first part of a selection marker, and a second construct comprising a second part of the selection marker, a copy of the endonuclease recognition site and a second region of homology with the target genome of the microorganism, whereby the first and second regions of homology with the target genome each comprises at least 20 base pairs (bp), whereby a fragment of the first part of the selection marker overlaps with a fragment that is present in the second part of the selection marker, allowing recombination between the first and second part of the selection marker; said fragment preferably comprising between 50 and 600 bp, whereby a coding sequence that encodes the endonuclease and which is coupled to an inducible promoter is present on the first or second construct; and whereby a part of the first region of homology with the
  • Said first and second regions of homology with the target genome each comprises at least 20 base pairs (bp).
  • bp base pairs
  • said first and second regions of homology preferably comprise between 20 bp and 100 kb, more preferred between 40 bp and 10 kb, more preferred between 50 bp and 5 kb, more preferred between 100 bp and 1 kb.
  • Said duplicated region of homology with the target genome on the first and second targeting construct preferably is between 20 and 500 bp, preferably between 20 and 200 bp, preferably between 40 and 100 bp, preferably about 80 bp.
  • Said duplicated region of homology with the target genome on the first and second targeting construct allows scarless removal of the marker from the target genome by homologous recombination.
  • the first construct preferably comprises, in this order, a first region of homology with a target gene of a microorganism, a recognition site for an endonuclease, and a first part of a selection marker.
  • the second construct preferably comprises, in this order, a second part of the selection marker, a coding sequence that encodes the endonuclease and which is coupled to an inducible promoter, a copy of the endonuclease recognition site, a copy of a part of the first region of homology with the target gene that is present on the first construct, and a second region of homology with the target gene of the microorganism.
  • This configuration is depicted in Figure 1 .
  • construct refers to an artificially constructed segment of nucleic acid.
  • a preferred construct is a vector, preferably a vector that contains bacterial resistance genes for growth in bacteria.
  • a most preferred construct is a plasmid, a linear or circular double-stranded DNA that is capable of replicating in bacteria independently of the chromosomal DNA.
  • the target gene can be any gene of a microorganism, preferably of a yeast, of which the genomic sequence is to be altered.
  • the term gene refers to a part of the genome of the microorganism that comprises intronic and exonic parts of a gene, the promoter region of said gene, and genomic sequences that mediate the expression of said gene, such as, for example enhancer sequences.
  • the targeting constructs can preferably be used to alter a gene of a microorganism.
  • the disclosure further provides a set of targeting constructs, comprising a first construct comprising a first region of homology with a target gene of a microorganism, a recognition site for an endonuclease, and a first part of a selection marker, and a second construct comprising a second part of the selection marker, a copy of the endonuclease recognition site and a second region of homology with the target gene of the microorganism, whereby a fragment of the first part of the selection marker overlaps with a fragment that is present in the second part of the selection marker, allowing recombination between the first and second part of the selection marker; whereby a coding sequence that encodes the endonuclease and which is coupled to an inducible promoter is present on the first or second construct; and whereby a part of the first region of homology with the target gene on the first construct is duplicate
  • alteration of the genomic sequence includes a replacement of one or more nucleotides, the insertion of one or more nucleotides, and/or the deletion of one or more nucleotides anywhere within a genome, preferably within a gene.
  • first and second region of homology with a target gene comprise adjacent genomic sequences of the gene
  • a replacement of one or more nucleotides in the first region of homology, and/or in the second region of homology will result in an alteration of the gene following homologous targeting with the set of targeting constructs according to the invention.
  • Said replacement of one or more nucleotides preferably is in the region of homology with the target gene that is present on the first and on the second construct.
  • Said alteration of the genomic sequence preferably is a deletion of one or more nucleotides, preferably anywhere within the gene.
  • the first and second region of homology with a target gene comprise genomic sequences of the gene that are separated on the genome of the organism, an alteration of the gene following homologous targeting with the set of targeting constructs according to the invention will result in a deletion of the region that was located between the first and second region of homology on the parental chromosome.
  • Said microorganism preferably is an aneuploid microorganism, preferably an aneuploid yeast.
  • aneuploidy refers to presence of an abnormal number of chromosomes within a cell or an organism that differs from the normal number of chromosomes for that organism.
  • An aneuploid microorganism may have one or more extra or missing chromosomes.
  • the term aneuploid microorganism includes a polyploid microorganism. In fungi, aneuploidy is known to confer antifungal drug resistance and enables rapid adaptive evolution [ Calo et al., (2013). PLoS Pathog 9(3): e1003181 ].
  • Said microorganism preferably aneuploid microorganism, preferably is an Ascomycota, preferably a Saccharomycotina, preferably a Saccharomyces sensu stricto (Saccharomyces paradoxus, S. mikatae, S. bayanus, S. eubayanus, S. kudriavzevii, S. paradoxus, S.
  • a preferred organism is the Lager brewing yeast Saccharomyces pastorianus.
  • S. pastorianus is supposed to be a hybrid of S. cerevisiae and S. eubayanus.
  • the genome size of S. pastorianus is up to 60% larger than that of S. cerevisiae, and includes large parts of the two genomes.
  • S. cerevisiae contains a haploid set of 16 chromosomes, ranging in size from 200 to 2,200 kb.
  • the genome size of S. pastorianus is 24-50 Mb. Additionally reported aneuploid Saccharomyces species are S. monacensis and S. uvarum. An overview of polyploid fungi is provided by Albertin and Marullo, (2012). Proc R Soc B 279: 2497-2509 .
  • Said selection marker is preferably an auxothrophic selection marker or a dominant selection marker, which are known to a skilled person.
  • Preferred auxotrophic markers include URA3, KlURA3; CaURA3; HIS3; his5; LEU2; KlLEU2; LYS2; TRP1; ADE1; ADE2; and MET15.
  • Preferred dominant markers include KanMX; Sh ble; hph; CUP1; SFA1; dehH1; PDR3-9; AUR1-C; nat; pat; ARO4-OFP; SMR1; FZF1-4; and DsdA.
  • Table 1 An overview of preferred markers that are routinely used in yeast organisms is provided in Table 1.
  • Said first construct preferably comprises a first part, preferably the first two-third or first half, of a region that encodes the selection marker.
  • URA3 also termed YEL021W, encodes the enzyme orotidine-5'-phosphate (OMP) decarboxylase which catalyzes the sixth enzymatic step in the de novo biosynthesis of pyrimidines, converting OMP into uridine monophosphate (UMP).
  • OMP orotidine-5'-phosphate
  • the encoded protein has 267 amino acids, which is encoded by a nucleic acid sequence of 801 base pairs (bp).
  • Said first construct preferably comprises between 200 and 600 bp of the coding region of URA3, more preferred between 300 and 500 bp.
  • the second construct preferably comprises between 200 and 600 bp of the coding region of URA3, more preferred between 300 and 500 bp.
  • the region of overlap between the first and second part of the selection marker preferably is between about 20 bp and 800 bp, preferably between about 50 bp and about 600 bp, preferably about 200 bp.
  • URA3 encodes orotidine 5-phosphate decarboxylase (ODCase), which is an enzyme that catalyzes a reaction involved in the synthesis of pyrimidine ribonucleotides in yeast RNA. Loss of ODCase activity leads to a lack of cell growth unless uracil or uridine is added to the media.
  • ODCase orotidine 5-phosphate decarboxylase
  • auxotrophic microorganisms can grow in the absence of uracil and/or uridine.
  • the addition of 5-fluoroorotic acid in the presence of a functional URA3 gene results in the formation of a toxic compound, causing death of the microorganisms.
  • URA3 allows for both positive and negative selection.
  • a further preferred selection marker is provided by a nucleotide sequence encoding either agmatine ureohydrolase (agmatinase) (EC.3.5.3.11) or guanidino-acid hydrolase (guanidinobutyrase; EC.3.5.3.7).
  • agmatine ureohydrolase agmatinase
  • guanidinobutyrase guanidinobutyrase
  • agmatinase and guanidinobutyrase present the essential characteristics of a potential dominant "gain of function" selectable marker in microorganisms such as S. cerevisiae, when grown on guanidinobutyrate and/or agmatine as sole nitrogen source.
  • a preferred guanidinobutyrase gene encodes a protein comprising the amino acid sequence of GenBank XP_456325.1, or a enzymatically active part thereof.
  • a preferred agmatine ureohydrolase gene encodes a protein comprising the amino acid sequence of GenBank AAC75974.1, or a enzymatically active part thereof.
  • Said selection marker is coupled to a promoter that directs expression of the selection marker in the microorganism, and a terminator that mediates efficient mRNA 3' end formation.
  • Said promoter preferably is a yeast promoter, preferably a yeast promoter selected from a glycolytic gene PGI1, PFK1, PFK2, FBA1, TPI1, TDH1, TDH3, PGK1, GPM1, ENOl, ENO2, and from ACT1, TEF1, AgTEF2, PMA1 promoter.
  • Said promoter can also be employed to express a dominant selection marker.
  • Terminators from a number of genes are known to the skilled person and have been employed, for example in expression vectors, including CYC1, TRP1, ADH1, MFl, FLP and D gene terminators ( Romanos et al., 1992. Yeast 8: 423-488 ).
  • the first or second targeting construct comprises a coding sequence that encodes an endonuclease and which is coupled to an inducible promoter.
  • the endonuclease preferably is a rare-cutting endonuclease such as, for example, PacI (target recognition sequence 5'-TTAATTAA); AscI (target recognition sequence 5'-GGCGCGCC), and AsiSI (target recognition sequence 5'-GCGATCGC). PacI, AscI and AsiSI are available from New England Biolabs.
  • the endonuclease more preferably is a homing endonuclease.
  • homing endonuclease refers to an endonucleases that is encoded either as freestanding genes within introns, as a fusion with a host protein, or as a self-splicing intein.
  • a preferred list of homing endonucleases is provided in Table 2. Additional examples of homing nucleases are I-DirI, I-NjaI, I-NanI, I-NitI, F-TevI, F-TevII, F-CphI, PI-MgaI, I-CsmI, which are all known to the skilled person. Further examples of homing nucleases are provided in Benjamin K (patent application US2012/052582 ).
  • a preferred homing nuclease is PI-PspI (New England Biolabs; recognition sequence 5'-TGGCAAACAGCTATTATGGGTATTATGGGT)) or PI-SceI (New England Biolabs; recognition sequence 5'-ATCTATGTCGGGTGCGGAGAAAGAGGTAAT).
  • the coding sequences of most homing endonuclease are known.
  • the coding sequence of PI-SceI and of PI-PspI are available from public databases (GenBank accession number Z74233.1 and Genbank accession number U00707.1, respectively).
  • the skilled person will understand that a sequence that differs from the publicly available sequence for a nuclease, may still encode the nuclease.
  • the term PI-PspI coding region includes a sequence that deviates from the publicly available sequence, for example by codon optimization, but which still expresses an active endonuclease that recognizes and digests the indicated target recognition sequence.
  • inducible promoter refers to a promoter of which the expression can be regulated.
  • inducible promoters are known to the skilled person. Examples of inducible promoters that have been employed in yeast are the GAL1 promoter and the GAL10 promoter, which both are inducible by galactose, the SUC2 promoter, which is inducible by sucrose, the MAL12 promoter, which is inducible by maltose; the CUP1 promoter, which is inducible by copper, and the tetO7 and tetO2 promoters, which are both inducible by tetracycline [ Gari et al., (1997). Yeast 13: 837-48 ; Yen et al., 2003). Yeast 20 1255-62 ].
  • a preferred inducible promoter is the GAL1 promoter.
  • One recognition site comprising the target recognition sequence for the endonuclease, is located adjacent to (behind) the first region of homology with a target gene of a microorganism on the first construct.
  • a copy of this recognition site is located adjacent to (in front of) the second region of homology with the target gene of the microorganism on the second construct.
  • the recognition site is located adjacent to (behind) the duplicated part of the second region of homology with the target gene on the first construct when a part of the second region of homology with the target gene on the second construct is duplicated on the first construct.
  • the selection marker including promoter and terminator sequences, and the coding region of the endonuclease, including the inducible promoter, are between the recognition site on the first construct and the copy of this recognition site on the second construct.
  • the invention further provides a method for altering a genome, preferably a target gene, in a microorganism, comprising providing the set of targeting constructs according to the invention to said microorganism, and selecting a microorganism in which the genome has been altered. Said selection of a microorganism in which the genome has been altered is preferably accomplished by selection of a microorganism that functionally expresses a recombined selection marker.
  • the occurrence of a recombination event between the targeting constructs is markedly enhanced after integration of the targeting constructs in the correct targeting locus.
  • the presence of a functionally recombined selection marker is highly indicative for the presence of correctly integrated targeting constructs in the target genome and, therefore, of an altered genome in the microorganism.
  • altering, alteration and altered refer to a replacement of one or more nucleotides, the insertion of one or more nucleotides, and/or the deletion of one or more nucleotides anywhere within the target gene.
  • a replacement of one or more nucleotides can be accomplished by altering one or more nucleotides in the first region of homology and/or in the second region of homology.
  • the first region of homology and the second region of homology cover adjacent regions of the genome, preferably target gene, the integration of the targeting vectors will result in an alteration of the genome.
  • said replacement of one or more nucleotides is preferably accomplished by altering one or more nucleotides in the overlapping region of homology with the genome that is present on the first and on the second construct.
  • Said alteration of a genomic sequence preferably is a deletion of one or more nucleotides anywhere within a genome, preferably within a gene.
  • first and second region of homology with a target genome comprise genomic sequences that are separated on the genome of the organism
  • an alteration of the genome following homologous targeting with the set of targeting constructs according to the invention will result in a deletion of the region that was located between the first and second region of homology on the parental chromosome.
  • the invention further provides a method for producing a microorganism comprising an altered genome, preferably an altered gene, the method comprising providing the set of targeting constructs according to the invention to said microorganism, and selecting a microorganism in which the genome has been altered and that functionally expresses a recombined selection marker.
  • the method for producing a microorganism comprising an altered genome preferably comprises inducing the inducible promoter for expression of the endonuclease, thereby removing the selection marker and the coding region of the endonuclease, including the inducible promoter, from the target genome.
  • the disclosure further provides a microorganism, comprising a genomic alteration that is produced by the methods of the invention.
  • a microorganism comprising a genomic alteration that is produced by the methods of the invention.
  • the duplicated regions of homology with the target genome on the first and second targeting construct ensure seamless marker removal from the target genome by homologous recombination.
  • the resulting microorganism comprises only the alteration or alterations that were present on the first and/or second targeting construct, or that were induced by recombination of the targeting constructs into the targeting genome, such as an insertion into the targeting genome or a deletion from the targeting genome.
  • the invention further provides a microorganism, comprising a genomic alteration, preferably an alteration of a target gene, the alteration comprising an insertion of a functionally recombined selection marker and a coding sequence for an endonuclease that is coupled to an inducible promoter, whereby the target genome comprises one copy of a recognition sequence for the endonuclease on both sites of the insertion.
  • the invention further provides a method for producing a microorganism comprising an altered genome, the method comprising providing a microorganism comprising an alteration of the genome, preferably of a target gene, the alteration comprising an insertion of a functionally recombined selection marker and a coding sequence for an endonuclease that is coupled to an inducible promoter, whereby the target genome comprises one copy of a recognition sequence for the endonuclease on both sites of the insertion, and inducing the inducible promoter to remove the nucleic acid sequences in between the recognition sequences of the endonuclease.
  • the duplicated regions of homology with the target gene on the first and second targeting constructs ensure seamless marker removal from the target genome by homologous recombination by providing the genomic DNA with a small homologous piece to re-connect the broken DNA strands efficiently.
  • the resulting microorganism comprises only the alteration or alterations that were present on the first and/or second targeting construct, or that were induced by recombination of the targeting constructs into the targeting genome, such as an insertion into the targeting genome or a deletion from the genome, preferably an insertion into a targeted gene or a deletion of the targeted gene or a deletion from within the targeted gene.
  • KlURA3 Repairs uracil deficiency Yes/negative selection with 5-FOA Shuster JR, Moyer D & Irvine B (1987) Sequence of the Kluyveromyces lactis URA3 gene. Nucleic Acids Res 15: 8573-8573 .
  • CaURA3 Repairs uracil deficiency Yes/negative selection with 5-FOA Losberger C & Ernst JF (1989) Sequence and transcript analysis of the C. albicans URA3 gene encoding Orotidine-5'-Phosphate Decarboxylase. Curr Genet 16: 153-157 .
  • HIS3 Repairs histidine deficiency No/-- Wach A, Brachat A, Alberti-Segui C, Rebischung C & Philippsen P (1997) Heterologous HIS3 marker and GFP reporter modules for PCR-targeting in Saccharomyces cerevisiae. Yeast 13: 1065-1075 . his5 Repairs histidine deficiency No/-- Wach A, Brachat A, Alberti-Segui C, Rebischung C & Philippsen P (1997) Heterologous HIS3 marker and GFP reporter modules for PCR-targeting in Saccharomyces cerevisiae. Yeast 13: 1065-1075 .
  • LYS2 Repairs lysine deficiency Yes/negative selection with alpha-aminoadipate Chattoo BB, Sherman F, Azubalis DA, Fjellstedt TA, Mehnert D & Ogur M (1979) Selection of lys2 mutants of the yeast Saccharomyces cerevisiae by the utilization of alpha-aminoadipate. Genetics 93: 51-65 .
  • ADE1 Repairs adenine deficiency No/-- Nakayashiki T, Ebihara K, Bannai H & Nakamura Y (2001) Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species ADE2 Repairs adenine deficiency No/-- Brachmann CB, Davies A, Cost GJ, Caputo E, Li JC, Hieter P & Boeke JD (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14: 115-132 .
  • Appl Environ Microb 70: 7018-7023 SMR1 Resistance to sulfometuron methyl No/-- Xie Q & Jimenez A (1996) Molecular cloning of a novel allele of SMR1 which determines sulfometuron methyl resistance in Saccharomyces cerevisiae. FEMS Microbiol Lett 137: 165-168 . FZF1-4 Increased tolerance to sulfite No/-- Cebollero E & Gonzalez R (2004) Comparison of two alternative dominant selectable markers for wine yeast transformation. Appl Environ Microb 70: 7018-7023 .
  • DsdA Resistance to D-Serine No/-- Vorachek-Warren MK & McCusker JH (2004) DsdA (D-serine deaminase): a new heterologous MX cassette for gene disruption and selection in Saccharomyces cerevisiae. Yeast 21: 163-171 . amdS Enable growth on acetamide Yes/ Fluoroacetamide Selten G, Swinkels B & Van Gorcom R (2000) Selection marker gene free recombinant strains: A method for obtaining them and the use of these strains. Pat.no. US6051431 .
  • SF Structural family
  • HI LAGLIDADG family
  • HII GIY-YIG family
  • HIII H-N-H family
  • HIV His-Cys box family.
  • D Biological domain of the source: A: archaea ; B: bacteria ; E: eukarya .
  • SCL Subcellularar location: chloro: chloroplast ; chrm: chromosomal ; mito: mitochondrial ; nuclear: extrachromosomal nuclear ; phage: bacteriophage .
  • yeast was grown in complex medium Yeast Peptone Dextrose (YPD) containing 10 g/L yeast extract, 20 g/L peptone, 22 g/L glucose 1 hydrate, pH 6), Synthetic Media (SM) containing 5.0 g/L (NH 4 ) 2 SO 4 , 3.0 g/L KH 2 PO 4 , 0.5 g/L MgSO 4 .7H 2 O, 1 mL/L trace elements solution and 1 mL/L of a vitamin solution (Verduyn et al., 1992) were used [ Verduyn et al., (1990). J General Microbiology 136: 395-403 ].
  • YPD Yeast Peptone Dextrose
  • SM Synthetic Media
  • the carbon source glucose was replaced by the alternative carbon source galactose with a concentration of 20 g/L.
  • liquid galactose medium When liquid galactose medium was used, growth was stimulated with addition of 0,0125% glucose.
  • yeasts that had correctly assembled the transformation fragments into the genomic DNA were grown in liquid YPD or MM culture. Yeasts with a correctly assembled plasmid, were grown under selective circumstances in a MM culture. After sufficient OD660 was reached, glycerol was added to obtain a concentration of 30% and the cells were stocked in a -80°C.
  • High-fidelity colony PCR was used to confirm insertion of the gene deletion cassette into the genomic DNA.
  • Cells from a liquid yeast culture 200 pL were spinned down, re-suspended in 100 pL of 0.2M LiAc with 1% of SDS solution and incubated for 5 minutes at 70°C. Addition of 96% ethanol and vortexing roughly, was followed by spinning down for 3 minutes at 15,000g. The pellet was washed with 70% ethanol and spinned down again. Ethanol was removed and the pellet was dried at a maximum temperature of 30°C, after which 100 pL of TE buffer was added to dissolve the pellet. Cell debris was spinned down for 30 seconds at 15,000g and 5 pL of the transferred supernatant was used for High-Fidelity colony PCR.
  • Restriction enzymes used in this project were supplied by Fermentas.
  • the digestion mix was either prepared in a total volume of 20 pL or 30 pL depending on the final amount desired.
  • a general mix contained 1 pL of each restriction enzyme (1 FastDigest unit/ ⁇ L), 2 or 3 pL of 10x FastDigest buffer and nuclease free demineralized water. Approximately 50-200ng DNA was used in a total mix of 20 ⁇ L and 100ng - 2pg in a total mix of 30pL.
  • the digestion mix was incubated at a temperature of 37°C.
  • nucleic acid molecules were loaded on 1% agarose gel (stained with 0.001% SybrSafe in advance) in 1x TAE buffer (40 mM Tris acetate and 1 mM EDTA). All DNA molecules were separated by applying an electric field of 100V for 30 min. Gel pictures were taken by exposing to UV light.
  • a gel extraction Kit (Sigma-Aldrich, Zwijndrecht, The Netherlands) was used. DNA fragment of interest was excised from the agarose gel with a blade. The DNA was extracted following the manufacturer recommendations.
  • a small volume of the plasmids (5 ⁇ L) was added to 50 ⁇ L One Shot TOP10 chemically competent cells (Life Technologies) and the protocol for chemical transformation of E. coli from the supplier was followed. Transformed cells were incubated at 37°C for one hour with shaking, allowing the cells to recover and build up the resistance to the used antibiotic. The cell suspension was plated on pre-warmed selective plates and incubated overnight at 37°C.
  • Cells with plasmids resulting from non-directional Blunt End TOPO cloning were plated on LB-agar plates (10 g tryptone, 5 g yeast extract, 10 g NaCl, 15 g/L agar) containing 50 ⁇ g/mL kanamycin (125 ⁇ L) or 100 ⁇ g/mL ampicillin (125 ⁇ L).
  • Cells with plasmids, that resulted from cutting and ligation in pUC19 were streaked on LB with 100 ⁇ g/mL ampicillin (250 ⁇ L). After overnight incubation, single colonies were re-streaked on fresh pre-warmed selective plates to grow overnight again. After re-streaking, selection of single E.
  • coli colonies was possible without background. Single colonies were inoculated into 5 mL LB medium with the appropriate antibiotic for overnight growth. Before isolation of the plasmids, 200 ⁇ L of glycerol solution was added to 800 ⁇ L of the culture, after which the sample was stored in -80°C freezer.
  • an E. coli culture with the required plasmid was grown overnight in LB medium. After pelleting a sample of 1-5 mL, the GenElute Plasmid Miniprep kit (Sigma-Aldrich) protocol was followed. At the last step 50 ⁇ L instead of 100 ⁇ L nuclease free demineralised water was used to elute the purified plasmid from the column.
  • the optical density (OD) was determined by the absorbance measured with a spectrophotometer at wavelength of 660 nm. With an OD660 between 0.6-0.8 (2 ⁇ 107 cells/mL for 10 transformations) or corrected for the amount of cells required for an individual transformation, the transformation was performed according to the lithium acetate single-stranded carrier DNA-polyethylene glycol method [ Gietz and Woods, (2002). Methods in Enzymology 350: 87-96 ]. Yeast cells were streaked on corresponding selective plates.
  • amdS-ISceI The central part of the complete gene deletion cassette, which will be called amdS-ISceI, consisted of the codon-optimized amdS gene and the I-SCEI under the galactose 1 promoter ( GAL1p ) flanked by two SceI recognition sites.
  • Primer sequences are provided in Table II.
  • the first fragment was constructed with the reverse primer Rv V1 SceI SacI, which binds to the start of the amdSYM cassette at the AgTEF2 promoter and which included an SceI recognition site and the SacI restriction site, and with the forward primer Fw V1 NdeI, which bound to the end of the intended 400 base overlap within amdS and included a NdeI restriction site at its 5' end ( Figure 1 ).
  • pUGamdS was used as template for vector 1 construction.
  • the PCR fragment vector 1 described above was cloned in pCR4Blunt-TOPO yielding the plasmid pUD266.
  • the last part of amdS was amplified from pUGamdS [ Solis-Escalante, D. et al. (2013). FEMS Yeast Research, 13:126-39 ] using the forward primer Fw V2 NdeI, that bound at the beginning of the intended 400 base pair overlap and included a NdeI restriction site to the PCR-product, and the reverse primer Rv V2-overlap-ISceI, to create an 60 base pair overlap to the GAL1 promoter that controlled the expression of I-SCEI. This fragment was named vector 2A.
  • the GAL1p -I-SCEI expression cassette was amplified from pUDC073 ( Kuijpers et al., 2013. FEMS Yeast Research.
  • the molar equivalents for two fragments were applied in the yeast transformation mix with the total amount of 837 ng of DNA: 337 ng for vector 1 with the 5' ScARO10 and 500 ng for vector 2 with 3' ScARO10.
  • S. pastorianus CBS1483 the transformation was repeated with 3,37 ⁇ g and 5 ⁇ g for both pieces, respectively.
  • PRG410 for generating IMC077 was performed several times, but only one plate contained positive orange colonies* Strain Transformants per ⁇ g DNA Standard Error of the Mean IMC067 (CEN.PK113-7D) 20563 1515 IMC076 (CEN.PK122) 5952 433 IMC077 (PRG410)* 19 - IMC064 (CBS 12357) 364 53 IMC066 (CMBS33) 278 85 CBS1483 0 -
  • the amdS marker was split in two part that shared an overlap of 400 base pairs within the amdS ORF.
  • the first part was obtained by amplifying the Ashbya gossipii TEF2 promoter and the first 1138 nucleotides of the amdS open reading frame from pUGamdSY.
  • the cloning in pCR4Blunt-TOPO plasmid of this fragment resulted in pUD266.
  • the second part of the bi partite marker system was constructed in two steps: 1) the second part of the marker included the last 908 base pairs of the amdS selectable marker and the AgTEF2 terminator. This cassette was flanked on its 3' end by an extension of 60 bp complementary to the SCEI cassette. 2) The endonuclease SCEI cassette which carried the SCEI gene under the control of the GAL1 promoter was amplified from pUDC073. On its 3' end this fragment harbored an additional endonuclease SceI restriction site. Subsequently, the two fragments were connected together by fusion PCR and the resulting fused fragment was cloned into the pCR4Blunt-TOPO vector yielding pUDC267.
  • restriction analysis was performed on pUDC266 with double digestion with NotI and BamH1, with Not1 cutting inside pCR4Blunt-TOPO plasmid and BamHI cutting only inside vector 1, which resulted in a characteristic band pattern of 438 and 5087 base pairs.
  • the restriction analysis was carried out with NotI and HindIII digestion resulting in a characteristic band pattern of 815 and 5732 base pairs.
  • the bi-partite fragment contained in pUDC266 was sequenced and revealed no mutation.
  • genomic DNA of CBS1483 was amplified with Fw 5'ScARO10 NotI and Rv 5'ScARO10 SacI for the upstream part of the ScARO10 and with Fw 3'ScARO10 BamHI 80bp and Rv 3'ScARO10 PstI for the downstream part.
  • the pUDC266 and pUD267 were digested with NotI/SacI and PstI/PmeI and ligated with the 5' fragment (NotI/SacI) and 3' fragment (PstI prepared), respectively. These ligations generated two new vectors pUD268 carrying the first selectable cassette element targeting the 5' side of the ScARO10 locus and pUD269 carrying the second selectable cassette element targeting the 3' side of the ScARO10 locus.
  • the first step is to successfully delete genes in several strains.
  • the targeted gene deletion with the two previously generated cassettes consisted of three essential recombination steps based on homology ( Figure 3A ).
  • the non-functional amdS parts located within both standard vectors were required to recombine and form a functional selectable amdS gene for growth on acetamide.
  • the other two steps were recombination between the 5' ScARO10 and 3'ScARO10 fragments on the cassette and those sites in the genomic DNA.
  • the homologous recombination of the overlap within amdS was also controlled with amdS primers KanA f and KanB r (2164 bp) and the homologous recombination of the 3' ScARO10 with inside-outside primers FK072 and Rv 3'ScARO10/amdS check (1081 bp). Because each strain contains more than one copy of ScARO10, except for CEN.PK113-7D, the presence of other copies of the ScARO10 was controlled with the primers ScARO10-Fw inside and ScARO10-Rv inside (959 bp).
  • the strain IMK490 (CBS1483 with one deleted locus Scaro10 ⁇ ::amdS ) was grown on a galactose medium to induce the GAL1 promoter that is controlling the expression of SCEI. ( Figure 3B ).
  • the strain IMK490 was grown on synthetic medium with galactose for 48hours. Upon induction, the endonuclease creates a cut at the SceI sites that flank the deletion cassette and in the meantime removes its coding region from the chromosome, therefore enabling a recycling of the genome editing construct.
  • strain IMK386, IMK487, IMK488 and IMK489 were treated similarly.
  • the galactose grown IMK490 cells were streaked on plates containing galactose as carbon source and were incubated at 30°C for 3 days.
  • Single colony isolates were resuspended in 100 ⁇ l of sterile water and 5 ⁇ l were transferred on synthetic media plates containing either ammonium or acetamide as sole nitrogen source. These plates were grown for 2 days at 30°C.
  • single isolate colonies of IMK386, IMK487, IMK488 and IMK489 were spotted on synthetic media plates containing either ammonium or acetamide as sole nitrogen source.
  • the second method used to remove the marker consisted in inoculating 1 mL of a culture from each strain containing the amdS-ISceI cassette in liquid medium with 2% galactose as main carbon source and 0.05% glucose to enhance growth of the different yeast strains. After growth for 4 hours in this liquid medium, samples were taken and diluted 200 times in sterile water and 100 ⁇ l were platted on synthetic medium with galactose and fluoroacetamide plates. Colonies that express the amdS gene would therefore hydrolyze fluoroacetamide in ammonium and fluoroacetate, which is toxic. Only cells having lost the amdS selectable marker would grow.
  • pUDC114 contained the carotene genes crtYBEI, which gave the positive colonies an orange colour as a means for quick identification.
  • the transformation results showed that with increasing ploidy of the different S. cerevisiae strains, the amount of transformants per ⁇ g DNA decreased significantly, from 2*10 4 transformants per ⁇ g DNA in haploid CEN.PK113-7D, to 6*10 3 transformants per ⁇ g DNA in the diploid CEN.PK122 and finally to 19 transformants per ⁇ g DNA in the polyploid ale brewing strain PRG410.
  • the amount of transformants per ⁇ g DNA was also more than 10 times lower than in the diploid laboratory strain CEN.PK122.
  • the efficiency of homologous recombination in the complex lager brewing strains was not investigated before.
  • the S. pastorianus CMBS33 was 20 times less efficient than the diploid CEN.PK122, but just slightly less efficient than the other parental strain S. eubayanus CBS12357.
  • the transformation efficiency and homologous recombination of the pUDC114 fragments in lager brewing strain CMBS33 was ⁇ 300 transformants per ⁇ g DNA, but zero for CBS1483. This proves that not all lager brewing strains are identical, with genetic differences determined by the particularities of the brewing process they were selected from.
  • the gene deletion system with the amdS marker removal by the endonuclease I-SceI is a novel way to alter and delete genes in lager brewing strains and laboratory S. cerevisiae strains.
  • the possibility of altering and/or deleting genes and subsequent marker removal in S. pastorianus CBS1483 with the amdS-ISceI cassette contributes substantially to the toolbox of researchers in the brewing industry.
  • Genomic DNA of the Kluyveromyces lactis strain ATCC 8585 was prepared as described ( Burke et al., 2000. Cold Spring Harbor Laboratory. Methods in yeast genetics: a Cold Spring Harbor Laboratory course manual ).
  • ORF KLLA0F27995g encoding KlGBU1
  • GBU1 forward primer 5'-CATCCGAACATAAACAACCATGAA GGTTGCAGGATTTATATTG
  • GBU1 reverse primer 5'-CAAGAAT CTTTTTATTGTCAGTACTGATCAGGCTTGCAAAACAAATTGTTC.
  • the coding sequence of the K. lactis GBU1 gene was obtained.
  • a set of targeting constructs comprising the selection marker KlGBU1 with all essential parts for the standard deletion cassette is provided in Figure 4 .
  • the 400 base overlap in the selection marker KlGBU1 (indicated by a cross) is designed to recombine due to the homology.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP14815085.7A 2013-12-06 2014-12-08 Novel genome alteration system for microorganisms Active EP3077521B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL14815085T PL3077521T3 (pl) 2013-12-06 2014-12-08 Nowy system do zmiany genomu dla mikroorganizmów

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2011912A NL2011912C2 (en) 2013-12-06 2013-12-06 Novel genome alteration system for microorganisms.
PCT/NL2014/050839 WO2015084178A1 (en) 2013-12-06 2014-12-08 Novel genome alteration system for microorganisms

Publications (2)

Publication Number Publication Date
EP3077521A1 EP3077521A1 (en) 2016-10-12
EP3077521B1 true EP3077521B1 (en) 2018-08-08

Family

ID=50190657

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14815085.7A Active EP3077521B1 (en) 2013-12-06 2014-12-08 Novel genome alteration system for microorganisms

Country Status (11)

Country Link
US (1) US20160369300A1 (ja)
EP (1) EP3077521B1 (ja)
JP (1) JP2016538865A (ja)
AU (1) AU2014357808A1 (ja)
BR (1) BR112016012686A2 (ja)
ES (1) ES2694349T3 (ja)
MX (1) MX2016007032A (ja)
NL (1) NL2011912C2 (ja)
PL (1) PL3077521T3 (ja)
RU (1) RU2694316C1 (ja)
WO (1) WO2015084178A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9879270B2 (en) * 2014-08-15 2018-01-30 Wisconsin Alumni Research Foundation Constructs and methods for genome editing and genetic engineering of fungi and protists
CN107550996A (zh) * 2017-10-25 2018-01-09 南京多宝生物科技有限公司 一种抑制胃酸分泌的枸橼酸铋钾胶囊及应用
CN108504682A (zh) * 2018-04-09 2018-09-07 西南大学 一种Cre/loxP基因删除系统及其应用
JP2022087881A (ja) * 2020-12-02 2022-06-14 トヨタ自動車株式会社 形質転換用プラスミド及びこれを用いた形質転換体の製造方法、並びに形質転換方法
CN112921049B (zh) * 2021-02-06 2024-01-23 石河子大学 一种用于生产香草醛的基因片段、酿酒酵母工程菌及其构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612205A (en) * 1990-08-29 1997-03-18 Genpharm International, Incorporated Homologous recombination in mammalian cells
US6436643B1 (en) * 1997-12-22 2002-08-20 Unilever Patent Holdings Bv Process for site-directed integration of multiple copies of a gene in a mould
PL2126130T3 (pl) * 2007-03-02 2015-10-30 Dupont Nutrition Biosci Aps Hodowle o ulepszonej fagooporności
EP2126100B1 (en) * 2007-03-21 2012-11-14 DSM IP Assets B.V. Improved method for homologous recombination
CA2754212C (en) * 2009-03-06 2016-08-02 Synthetic Genomics, Inc. Methods for cloning and manipulating genomes
US7919605B1 (en) 2010-08-30 2011-04-05 Amyris, Inc. Nucleic acids, compositions and methods for the excision of target nucleic acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
AU2014357808A1 (en) 2016-06-16
WO2015084178A1 (en) 2015-06-11
BR112016012686A2 (pt) 2017-08-08
NL2011912C2 (en) 2015-06-09
US20160369300A1 (en) 2016-12-22
ES2694349T3 (es) 2018-12-20
MX2016007032A (es) 2016-10-28
PL3077521T3 (pl) 2019-02-28
EP3077521A1 (en) 2016-10-12
JP2016538865A (ja) 2016-12-15
RU2694316C1 (ru) 2019-07-11

Similar Documents

Publication Publication Date Title
US11390888B2 (en) Methods for genomic integration
US9879270B2 (en) Constructs and methods for genome editing and genetic engineering of fungi and protists
US20200190540A1 (en) Genetic targeting in non-conventional yeast using an rna-guided endonuclease
EP3077521B1 (en) Novel genome alteration system for microorganisms
Abdel‐Banat et al. Random and targeted gene integrations through the control of non‐homologous end joining in the yeast Kluyveromyces marxianus
US7919605B1 (en) Nucleic acids, compositions and methods for the excision of target nucleic acids
US11299754B2 (en) Gene targeting method
EP2783000A1 (en) Nucleic acid assembly system
Meng et al. Efficient CRISPR/Cas9 system based on autonomously replicating plasmid with an AMA1 sequence and precisely targeted gene deletion in the edible fungus, Cordyceps militaris
EP3129486B1 (en) Ureohydrolases as dominant selectable markers in yeast
Bizzarri et al. A set of plasmids carrying antibiotic resistance markers and Cre recombinase for genetic engineering of nonconventional yeast Zygosaccharomyces rouxii
Liu et al. Scarless gene deletion using mazF as a new counter-selection marker and an improved deletion cassette assembly method in Saccharomyces cerevisiae
JP2009178104A (ja) ヘテロ接合性の消失を利用した二倍体細胞染色体特定領域のホモ化方法
Dmytruk et al. Molecular mechanisms of insertional mutagenesis in yeasts and mycelium fungi
Juergens et al. Genome editing in Kluyveromyces and Ogataea yeasts using a
Gast et al. Development of methodologies for targeted mutagenesis in Kluyveromyces marxianus
Liu et al. Short Communication Scarless gene deletion using mazF as a new counter-selection marker and an improved deletion cassette assembly method in Saccharomyces cerevisiae

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160627

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180221

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GEERTMAN, JAN-MAARTEN

Inventor name: BOLAT, IRINA

Inventor name: DARAN, JEAN-MARC GEORGES

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BOLAT, IRINA

Inventor name: DARAN, JEAN-MARC GEORGES

Inventor name: GEERTMAN, JAN-MAARTEN ANTON

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1027049

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180815

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014030132

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2694349

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20181220

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1027049

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180808

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181208

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181109

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181108

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181108

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014030132

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20190509

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181208

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20141208

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180808

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180808

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230522

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20231121

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231220

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231228

Year of fee payment: 10

Ref country code: FR

Payment date: 20231221

Year of fee payment: 10

Ref country code: DE

Payment date: 20231214

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20231124

Year of fee payment: 10

Ref country code: BE

Payment date: 20231220

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240129

Year of fee payment: 10